Tag: UK Study
-
Metformin Reduces Long COVID Risk: Key Insights from UK Study
Introduction In a groundbreaking UK study, researchers have uncovered that Metformin, a widely used and affordable diabetes medication, can significantly lower the risk of Long COVID by a remarkable 64%. This finding particularly highlights the potential benefits for overweight individuals who are already at higher risk of severe COVID-19 outcomes. With Long COVID affecting countless…